Managing Partner at Vivo Capital
View Live Interactive Profile →Michael Chang is a Managing Partner of Vivo Capital. He joined Vivo with a background in healthcare strategy and operations, having worked at Johnson & Johnson in the strategy and commercial planning function and as a strategy consultant at Booz & Company and Fletcher Spaght. He holds a bachelor's degree in Economics from Harvard College and an M.B.A. from Harvard Business School. Bolt Biotherapeutics' April 2026 proxy statement identifies him as a voting member of both Vivo GP and Vivo PANDA GP. He was quoted as Managing Partner in the 3 February 2026 announcement of Vivo Capital's acquisition of the European laboratory distribution business Dutscher Group from LBO France. Vivo does not publish a joining year for him.